Table 2.
Postdischarge Outcomes Among Patients With Type 2 MI (N=289)
| Outcome | 30 Days | 180 Days | 365 Days |
|---|---|---|---|
| Traditional outcomes | |||
| All‐cause mortality, N (%) | 11 (3.8%) | 46 (15.9%) | 67 (23.2%) |
| Cardiovascular death, N (%) | 2 (0.7%) | 14 (4.8%) | 24 (8.3%) |
| Time‐to‐event all‐cause mortality, mean (SD) | 29.5 (3.0) | 163.7 (42.9) | 312.7 (108.2) |
| All‐cause rehospitalization, N (%) | 75 (26.0%) | 162 (56.1%) | 200 (69.2%) |
| Time‐to‐event all‐cause rehospitalization, mean (SD) | 25.3 (9.0) | 108.3 (73.8) | 174.0 (148.6) |
| All‐cause mortality or readmission, N (%) | 79 (27.3%) | 175 (60.6%) | 215 (74.4%) |
| Time‐to‐event all‐cause mortality or readmission, mean (SD) | 25.1 (9.1) | 103.7 (73.4) | 160.3 (143.7) |
| MACE (all‐cause mortality, MI, or stroke), N (%) | 24 (8.3%) | 75 (26.0%) | 101 (34.9%) |
| Time‐to‐event MACE (all‐cause mortality, MI, or stroke), mean (SD) | 28.5 (5.2) | 150.0 (57.1) | 277.9 (133.2) |
| Home‐time | |||
| Home‐time, mean days (SD) | 21.6 (11.7) | 138.0 (62.5) | 270.1 (133.5) |
| Home‐time, median days (IQR) | 30 (16–30) | 171 (133–180) | 347 (203–362) |
| 0% home‐time, N (%) | 53 (18.3%) | 29 (10.0%) | 29 (10.0%) |
| 100% home‐time, N (%) | 150 (51.9%) | 87 (30.1%) | 57 (19.7%) |
IQR indicates interquartile range; MACE, major adverse cardiovascular event; MI, myocardial infarction; N, number; and SD, standard deviation.